Filing Details

Accession Number:
0001232524-14-000142
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-10 18:25:06
Reporting Period:
2014-11-07
Filing Date:
2014-11-10
Accepted Time:
2014-11-10 18:25:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1615764 Iain Mcgill C/O Jazz Pharmaceuticals Plc
Connaught House, 1 Burlington Rd, Fl. 4
Dublin 4 L2
Head Of Eusa Int'l & Svp No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2014-11-07 4,166 $46.83 28,990 No 4 M Direct
Ordinary Shares Acquisiton 2014-11-07 1,500 $59.13 30,490 No 4 M Direct
Ordinary Shares Disposition 2014-11-07 5,666 $172.03 24,824 No 4 S Direct
Ordinary Shares Disposition 2014-11-07 1,400 $172.00 23,424 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Nonstatutory Stock Option (right to buy) Disposition 2014-11-07 4,166 $0.00 4,166 $46.83
Ordinary Shares Nonstatutory Stock Option (right to buy) Disposition 2014-11-07 1,500 $0.00 1,500 $59.13
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,334 2022-08-08 No 4 M Direct
7,000 2023-03-04 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172 to $172.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  2. Following the reported transaction, the remaining ordinary shares subject to this option vest in equal monthly installments from November 9, 2014 to August 9, 2016.
  3. Following the reported transaction, the remaining ordinary shares subject to this option vest in equal monthly installments from December 5, 2014 to March 5, 2017.